Diabetes: Page 2

  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom

    Dexcom CEO discusses 2023 plans, expanding to more patients with Type 2 diabetes

    MedTech Dive caught up with Kevin Sayer for a conversation about forthcoming product launches and long-term plans to expand CGMs to a broader group of patients. 

    By Updated Jan. 20, 2023
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories

    How Abbott plans to make its Freestyle Libre a $10B product

    CEO Robert Ford discussed plans to grow the market for Abbott’s continuous glucose monitors, and its broader diabetes strategy.

    By Jan. 10, 2023
  • Intuitive Surgical da Vinci robot, surgeon at surgeon console Explore the Trendline
    Image attribution tooltip
    Courtesy of Intuitive Surgical

    More mergers, new diabetes devices and the road to MDR: Medtech trends in 2023

    Medical device leaders expect financial pressures to ease as companies navigate regulatory changes in Europe, planned spinoffs and product launches.

    By MedTech Dive staff
  • A portrait of Steven Russell, MD
    Image attribution tooltip
    Courtesy of Beta Bionics

    Beta Bionics hires Harvard diabetes expert as CMO ahead of artificial pancreas launch

    Steven Russell has joined the company as chief medical officer, completing a new leadership team that began taking shape with the appointment of Sean Saint as CEO last year.

    By Jan. 10, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom

    Dexcom forecasts 2023 revenue to rise as much as 20% on G7 launch

    Sales are expected to reach $3.35 billion to $3.49 billion for the full year.

    By Jan. 9, 2023
  • Medtronic's MiniMed 780G Advanced Hybrid Closed Loop System
    Image attribution tooltip
    Courtesy of Medtronic

    ‘Mea culpa’: What Goldman Sachs analysts got wrong about Medtronic in 2022

    Medtronic has struggled to deliver on key projects in recent years, leading to a decline in its stock performance.

    By Jan. 4, 2023
  • Medicine for diabetes disease of health care and self-care concept. Plus size African American woman with syringe making insulin injections at abdominal skin (intra subcutaneous) for hyperglycemia by
    Image attribution tooltip
    Pixelseffect via Getty Images

    As diabetes technology advances, blood glucose control declines: study

    Mexican-American and non-Hispanic Black adults saw the greatest drop as the proportion of patients with glycemic control fell from 29.2% between 1988 and 1994 to 27.5% between 2013 and 2020.

    By Dec. 21, 2022
  • Concept image of insulin aspart with fake labeling
    Image attribution tooltip
    Samara Heisz via Getty Images

    Novo Nordisk expands Amalgam Rx insulin app pact, plots integration with other devices

    Supported by Novo Nordisk, Amalgam Rx will incorporate and integrate with connected insulin delivery devices, continuous glucose monitors and electronic health records.

    By Dec. 20, 2022
  • The Dexcom G7 Continuous Glucose Monitor
    Image attribution tooltip
    Courtesy of Dexcom

    Dexcom’s Jake Leach discusses preparations for G7 launch next year

    The diabetes tech company is in conversations with payers and is opening a new manufacturing plant ahead of the planned launch of its newest CGM, the COO said. 

    By Dec. 15, 2022
  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes

    Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market

    The deal will give Tandem control of Sigi, a reusable, rechargeable patch pump that is designed to be smaller and lighter than existing devices.

    By Dec. 14, 2022
  • Ypsomed's YpsoPump for diabetes management
    Image attribution tooltip
    Courtesy of Ypsomed

    Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal

    The companies planned to launch a customized version of the YpsoPump that used pre-filled insulin cartridges for Lilly’s rapid-acting insulins.

    By Dec. 12, 2022
  • The Dexcom G7 Continuous Glucose Monitor
    Image attribution tooltip
    Courtesy of Dexcom

    Dexcom’s G7 glucose monitor wins awaited FDA clearance

    The new Dexcom monitor is expected to generate significant patient demand, as it has been cleared by the FDA for patients with Type 1 and Type 2 diabetes, as well as gestational diabetes.

    By Dec. 8, 2022
  • A visiting nurse helps a patient at home with CGM monitoring
    Image attribution tooltip
    Phynart Studio/Getty via Getty Images

    AI detects prediabetes in CGM data, opening up new use for device: study

    By correctly identifying many patients with prediabetes or Type 2 diabetes, researchers say CGMs can be used to prevent the disease. 

    By Dec. 6, 2022
  • Team of surgeons operating on patient in hospital - stock photo Four doctors in hospital operating room with patient lying on operating table. Surgical lights shining on medical team performing operat
    Image attribution tooltip
    Johnny Greig via Getty Images

    The 10 biggest medtech stories of 2022

    MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

    By MedTech Dive staff • Dec. 3, 2022
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta

    Friday Q&A: Embecta CEO talks BD spinoff, future of diabetes devices

    Dev Kurdikar spoke with MedTech Dive about developing an insulin pump for patients with Type 2 diabetes and what’s next for the firm.

    By Nov. 18, 2022
  • A patient being examined for retinal problems related to diabetes
    Image attribution tooltip
    Courtesy of AEYE Health

    AEYE Health wins FDA clearance for AI-powered eye test to expand diabetic screening

    Approval is a first step to letting primary care physicians use a hand-held camera backed by AI to diagnose potential diabetic-related sight issues.

    By Nov. 18, 2022
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.

    Insulet warns Omnipod 5 insulin pump charge issue may cause fire

    Rapid sales growth at the company has come amid safety problems involving some of its devices.

    By Nov. 17, 2022
  • A Medtronics diabetes device
    Image attribution tooltip
    Courtesy of https://news.medtronic.com/MiniMed-R-670G-Hybrid-Closed-Loop-System#assets_34137_21-122

    Medtronic doubles wear time of insulin pump infusion sets

    The company calculated users of its extended-wear system will change their devices 75 fewer times, resulting in annual savings of more than $1,000.

    By Nov. 16, 2022
  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes

    Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics

    Patients with Type 2 diabetes spent 3.6 hours per day longer in the target blood glucose range after switching to Tandem’s system, a study found.

    By Nov. 14, 2022
  • A Lilly Tempo diabetes device
    Image attribution tooltip
    Courtesy of Eli Lilly

    Lilly’s new diabetes management platform to integrate Dexcom CGM

    The launch comes seven years after the company began investing in device R&D to counter pricing pressures.

    By Nov. 9, 2022
  • A woman lifting her shirt to expose her midriff and show a Verily Onduo CGM
    Image attribution tooltip
    Courtesy of Verily

    Verily’s Onduo cut blood sugar in retrospective study of Type 2 diabetics

    Participants with high blood sugar at baseline benefited the most from Onduo, a study found.

    By Nov. 8, 2022